Viveve Medical, Inc.
VIVE
$0.0002
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 4.21% | 8.52% | 13.17% | -12.38% | 6.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.21% | 8.52% | 13.17% | -12.38% | 6.04% |
| Cost of Revenue | -24.23% | 0.81% | 23.69% | 2.76% | 17.07% |
| Gross Profit | 378.95% | 78.18% | -16.23% | -116.60% | -52.70% |
| SG&A Expenses | 17.07% | 15.80% | 2.01% | -3.58% | 5.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.72% | 3.27% | 8.13% | 22.70% | 44.24% |
| Operating Income | 15.11% | -1.52% | -6.71% | -38.49% | -61.34% |
| Income Before Tax | 15.06% | -43.19% | -1.64% | -33.33% | -59.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.06% | -43.19% | -1.64% | -33.33% | -59.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -13.33% | -- |
| Net Income | 15.06% | -43.19% | -1.64% | -33.08% | -56.84% |
| EBIT | 15.11% | -1.52% | -6.71% | -38.49% | -61.34% |
| EBITDA | 14.45% | -4.21% | -9.75% | -43.95% | -69.71% |
| EPS Basic | 10.90% | -35.64% | 15.84% | 73.54% | 74.87% |
| Normalized Basic EPS | 15.65% | 0.92% | 17.35% | 72.81% | 73.46% |
| EPS Diluted | 10.90% | -35.64% | 15.84% | 73.54% | 74.87% |
| Normalized Diluted EPS | 15.65% | 0.92% | 17.35% | 72.81% | 73.46% |
| Average Basic Shares Outstanding | 0.69% | 1.33% | 22.97% | 388.93% | 485.86% |
| Average Diluted Shares Outstanding | 0.69% | 1.33% | 22.97% | 388.93% | 485.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
